Objective: to evaluate the use of a bacterial cellulose biopolymer film and gel dressing in the treatment of patients with ischemic wounds submitted to lower limb revascularization. Methods: we conducted a randomized clinical trial in the Angiology and Vascular Surgery outpatient clinic of the Clinics Hospital of the Federal University of Pernambuco, between January 2017 and December 2018. We followed 24 patients after lower limb revascularization, divided into two groups: Experimental, treated with bacterial cellulose biopolymer film and gel, and Control, treated with essential fatty acids. Patients attended weekly appointments to change dressings and had their wound healing processes evaluated over a period of 90 days. Results: the reduction of the ischemic wounds' areas after 30 days was 4.3cm 2 (55%) on average for the experimental group, and the 5.5cm 2 (48.5%) for the control group (p>0.05). The complete healing rate at 90 days was 34.8%, 50% in the experimental group and 18.2% in the control group (p=0.053). Conclusion: the bacterial cellulose biopolymer film associated with gel can be used as a dressing in the treatment of ischemic wounds of patients undergoing revascularization of the lower limbs.
INTRODUCTION
T he most severe manifestation of lower limbs (LL) peripheral obstructive arterial disease (PAD) is the ischemic wound (IW). It occurs most often in the foot and leg and is associated with a high risk of limb loss 1 . Most patients with IW are candidates for open or endovascular arterial revascularization surgery, which aims to restore blood flow to the lower limb and thus avoid major amputations (above the ankle joint), which cause a significant deterioration in quality of life and increased mortality. Hardly accessible, alternative therapy already exists, such as the use of stem cells, but this is still not able to replace revascularization procedures [1] [2] [3] .
In addition to arterial revascularization surgery, patients with IW often undergo surgical debridement and minor amputations. These procedures are performed after revascularization surgeries and aim to promote the removal of devitalized and infected tissues, and to facilitate the healing process [1] [2] [3] . Thus, there is need for dressings, performed at the outpatient level. There are many materials used in these dressings, most also used in venous and lymphatic ulcers. There is no standardization as to the material used in the dressings of such wounds, and several protocols are used [1] [2] [3] .
The bacterial cellulose biopolymer film with associated gel (CBFG) is a nontoxic and biocompatible material that has been studied in various areas of medicine. It has been used in animal experiments as an arterial substitute and to fill eviscerated eyeballs.
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In humans, it has been tested in several areas of medicine, including dressings. It had satisfactory results in patients with venous ulcers, but had not yet been used as IW cover, which presents a distinct behavior from venous ulcers.
The aim of this study is to evaluate the use of CBFG in the treatment of IW after revascularization of the lower limbs 4-10 .
METHODS
We study 24 patients presenting IW in The study was a simple, prospective, randomized intervention study.
We randomized and distributed patients as follows: 13 patients in the group with film and gel biopolymer dressing (Experimental Group -EG) and 11 in the control group, with essential fatty acids (EFA) and gauze (Control Group -CG). We followed all individuals at the HC-UFPE Vascular Surgery Outpatient Clinic in weekly appointments, when we performed the clinical evaluation and dressing change, for a period of 90 days. We assessed the IW using the MEASURE 11 methodology.
CG patients underwent application of EFA to the wound and covered with gauze and fixed with bandages. EG patients were treated by applying a primary dressing composed of biopolymer gel applied directly to the IW bed and covered with the same biopolymer film (membrane) ( Figure 1 ). This primary dressing was also covered with gauze and fixed with bandage, used only as a secondary dressing in this group. We instructed CG patients to daily and completely change the dressing after the bath, cleaning the wound, reapplying EFA and a new cover with gauze, according to the Service protocol. We oriented EG individuals to the same procedure, but only by changing the secondary dressing (gauze), without removing the membrane directly adhered to the ulcer (primary dressing).
We photographed all wounds with the same NIKON 3200 digital camera at baseline and at reevaluations for monitoring responses to the therapeutic measures.
We performed the statistical analysis with the GraphPad Prism 4.0 (GraphPad Software Inc., USA) and SigmaPlot 12.0 (Systat Software, Inc., Germany) softwares. We expressed continuous variables as mean and standard deviation or median and interquartile range 25%-75%, and mean difference and 95% confidence interval. As for the evaluation through MEASURE, there was no statistical difference between the two groups on the first day of evaluation (Table 3 ).
There was also no statistical difference in any MEASURE parameter between groups over a 30-day period. Both dressings showed a significant reduction in length and width (EG of -0.7cm and -0.7cm, and CG, -0.9cm and -0.9cm, respectively) (p<0.05). EG had a depth reduction of 0.4cm, while CG had a reduction of 0.1cm, with statistical significance in favor of EG (p=0.046) (Figures 2 and 3 ). There was no statistical difference in the reduction of IW area within 30 days. It was 4.3 cm 2 (55%) in average for EG, and 5.5cm 2 (48.5%) or CG (p>0.05).
Both groups showed a significant IW area reduction (Tables 4 and 5 ).
The 90-day complete healing rate was 34.8% (8 cases), 50% (6 cases) in the EG and 18.2% (2 cases) in the CG, but without statistical significance (p=0.193).
We could not assess one EG patient because he died of cardiac complications (acute myocardial infarction) at 45 days of follow-up (Figures 4 and 5 ).
DISCUSSION
PAD affects patients of full age, the average age of patients in this study being 67.4 years. This result is similar to those found in the literature and is justified because PAD has a higher prevalence from the sixth decade of life on [12] [13] [14] .
The evaluated sample had an equal number of patients in both sexes. Atherosclerosis is known to affect men earlier, but after menopause, the incidence in women tends to equal the opposite sex. These facts make the groups equal in the prevalence of PAD in the older ages strata, as revealed in this research. Another aspect to be noted is that men die earlier than women due to atherosclerotic disease [12] [13] [14] .
The most prevalent risk factors for PAD in the study sample were SAH, DM and smoking. These results are similar to those described in the literature and are related to the development of atherosclerosis.
In addition, several studies link smoking and DM to progression to more severe forms of PAD.
There fore, diabetic patients and/or smokers have increased risk of developing gangrene or IW [12] [13] [14] .
Lower limb revascularization surgery is The main factor for IW healing is good distal limb perfusion. The area of the lesions, the criteria for surgical reintervention used and the follow-up of the graft or treated artery patency may also influence IW healing [20] [21] [22] .
We used The MEASURE method to standardize the IW assessment. We found a predominance of delimited wounds, with little exudate, rich in granulation tissue and without detachment.
After adequate revascularization of the limb affected by PAD and surgical debridement to remove devitalized tissues, there is an expected decrease in the frequency of exudative wounds, which are more superficial an prone to granulation progression.
In this study, we randomized patients only after surgical treatment of ischemia and wounds and, therefore, characteristics such as good granulation, little exudate and IW delimitation were similar in both groups 23 .
The fact that CBFG was changed weekly without impairing healing results seems to be an important factor in patient adherence to treatment. In A limitation of this study was the nonclassification and comparison of patients according to angiosome revascularization criteria, which is a current trend in vascular surgery 23 . We did not proceed this way because we included for evaluation only patients whose surgical treatment was successful, and probably the affected angiosome had been adequately revascularized. Another limitation to be considered is the small number of patients evaluated, which may have influenced the statistical results obtained as described in the previous paragraph.
The good results achieved by CBFG in IW healing and its good tolerance by patients increase the possibility of its use in the short/ medium term. We conclude that the sugarcane biopolymer gelatinous film-based dressing can be used for the treatment of ischemic wounds after revascularization of the lower limbs. 
